We are live on ! Find out more
MOS

MGO One Seven Portfolio holdings

AUM $4.98B
1-Year Est. Return 22.72%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+22.72%
3 Year Est. Return
+73.8%
5 Year Est. Return
+90.34%
10 Year Est. Return
AUM
$964M
AUM Growth
+$176M
Cap. Flow
+$157M
Cap. Flow %
16.24%
Top 10 Hldgs %
20.15%
Holding
697
New
93
Increased
410
Reduced
127
Closed
32

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20.7M
2
PG icon
Procter & Gamble
PG
+$10.7M
3
MSFT icon
Microsoft
MSFT
+$7.48M
4
HD icon
Home Depot
HD
+$5.58M
5
JPM icon
JPMorgan Chase
JPM
+$5.22M

Sector Composition

Rank Sector Weight
1 Technology 18.37%
2 Financials 9.17%
3 Healthcare 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTIP icon
76
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$2.96M 0.31%
57,683
+4,321
+8% +$225K
LQD icon
77
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
$2.94M 0.31%
22,220
+1,285
+6% +$171K
BA icon
78
Boeing
BA
$167B
$2.94M 0.31%
14,614
+1,981
+16% +$419K
TMO icon
79
Thermo Fisher Scientific
TMO
$208B
$2.93M 0.3%
4,391
+1,530
+53% +$955K
AAP icon
80
Advance Auto Parts
AAP
$3.48B
$2.93M 0.3%
12,207
+136
+1% +$31.1K
TGT icon
81
Target
TGT
$63.7B
$2.92M 0.3%
12,624
+1,692
+15% +$411K
MAS icon
82
Masco
MAS
$16.4B
$2.83M 0.29%
40,301
+534
+1% +$34.5K
PEP icon
83
PepsiCo
PEP
$191B
$2.8M 0.29%
16,105
+6,402
+66% +$1.05M
FXO icon
84
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$2.79M 0.29%
60,319
+774
+1% +$36.1K
T icon
85
AT&T
T
$167B
$2.76M 0.29%
148,753
+28,609
+24% +$535K
HOMB icon
86
Home BancShares
HOMB
$6.21B
$2.73M 0.28%
112,108
-5,146
-4% -$127K
ABBV icon
87
AbbVie
ABBV
$454B
$2.66M 0.28%
19,648
+10,651
+118% +$1.26M
PFF icon
88
iShares Preferred and Income Securities ETF
PFF
$13.2B
$2.58M 0.27%
65,571
+4,485
+7% +$174K
DEO icon
89
Diageo
DEO
$47.3B
$2.58M 0.27%
15,484
+2,487
+19% +$510K
VBK icon
90
Vanguard Small-Cap Growth ETF
VBK
$23.3B
$2.56M 0.27%
9,092
-813
-8% -$233K
CI icon
91
Cigna
CI
$77B
$2.55M 0.26%
11,094
+944
+9% +$201K
XOM icon
92
ExxonMobil
XOM
$642B
$2.53M 0.26%
41,408
+6,248
+18% +$390K
LLY icon
93
Eli Lilly
LLY
$1.07T
$2.5M 0.26%
9,052
+1,506
+20% +$382K
NVS icon
94
Novartis
NVS
$297B
$2.48M 0.26%
32,930
-1,133
-3% -$94.1K
RTX icon
95
RTX Corp
RTX
$294B
$2.47M 0.26%
28,698
+2,057
+8% +$179K
VWO icon
96
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$2.44M 0.25%
49,374
+2,010
+4% +$101K
EMR icon
97
Emerson Electric
EMR
$83.6B
$2.4M 0.25%
25,816
+3,677
+17% +$346K
ABT icon
98
Abbott
ABT
$182B
$2.39M 0.25%
16,994
+7,090
+72% +$908K
PODD icon
99
Insulet
PODD
$11.4B
$2.39M 0.25%
8,968
+27
+0.3% +$7.83K
UL icon
100
Unilever
UL
$132B
$2.35M 0.24%
38,914
+4,462
+13% +$265K

Similar funds

MGO One Seven's Q4 2021 Portfolio in Review

As of Q4 2021, MGO One Seven held 697 positions worth $964M, up 22% from $788M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MGO One Seven deployed $157M of net new capital in Q4 2021, opening 93 new positions and adding to 410 existing holdings. Its largest new stake was Fifth Third Bancorp: 24,635 shares worth $1.07M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $2.21M trimmed.

  • MGO One Seven's largest Q4 2021 buy was Fifth Third Bancorp: 24,635 shares worth $1.07M.
  • MGO One Seven added most to Apple in Q4 2021, an estimated $20.7M increase.
  • MGO One Seven's biggest Q4 2021 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $2.21M.
  • MGO One Seven fully exited KLA in Q4 2021, selling an estimated $994K.
  • MGO One Seven's ten largest holdings make up 20% of its $964M portfolio in Q4 2021.
  • MGO One Seven opened 93 new positions and closed 32 in Q4 2021.
  • MGO One Seven's portfolio value rose 22% quarter-over-quarter to $964M.

Based on MGO One Seven's 13F filing for Q4 2021, filed 9 Feb 2022.